Fast Five Quiz: Janus Kinase Inhibitors for Psoriatic Arthritis

Evan Dombrosky, MD

December 13, 2024

Psoriatic arthritis is a chronic inflammatory arthritic disease with a range of treatment options from nonsteroidal anti-inflammatory drugs (NSAIDs), glucocorticoids, and disease-modifying antirheumatic drugs (DMARDs). Methotrexate is the classic conventional synthetic DMARD (csDMARD) for psoriatic arthritis, but treatment failure can occur. In this case, a number of biologic DMARDs (bDMARDs) and targeted-synthetic DMARDs (tsDMARDs) are also available to control disease activity.

Janus kinase inhibitors (JAKIs) are one of the tsDMARDs that have recently been used to treat psoriatic arthritis. Although significant efficacy has been demonstrated, JAKIs are not without their own safety concerns and other nuances for use.

How much do you know about JAKI use in patients with psoriatic arthritis? Test your knowledge with this quick quiz.

1 2 3 4 5 6

Next Section

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Cite this: Fast Five Quiz: Janus Kinase Inhibitors for Psoriatic Arthritis - Medscape - Dec 13, 2024.

Comments

Commenting is limited to medical professionals. To comment please Log-in.

Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....

Fast Five Quiz: Janus Kinase Inhibitors for Psoriatic Arthritis

Tables

Authors and Disclosures

Authors and Disclosures

Expert(s)

Evan Dombrosky, MD

Comments

Email This

Feedback